Search Results - "Leight, Susan N"
-
1
Conformation-selective tau monoclonal antibodies inhibit tau pathology in primary neurons and a mouse model of Alzheimer's disease
Published in Molecular neurodegeneration (04-11-2020)“…The spread of tau pathology in Alzheimer's disease (AD) is mediated by cell-to-cell transmission of pathological tau seeds released from neurons that, upon…”
Get full text
Journal Article -
2
Thromboxane Receptor Activation Mediates Isoprostane-Induced Increases in Amyloid Pathology in Tg2576 Mice
Published in The Journal of neuroscience (30-04-2008)“…Alzheimer's disease (AD) amyloid plaques are composed of amyloid-beta (Abeta) peptides produced from proteolytic cleavage of amyloid precursor protein (APP)…”
Get full text
Journal Article -
3
Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies
Published in Journal of neuropathology and experimental neurology (01-03-2018)“…Abstract Aggregation of tau into fibrillar structures within the CNS is a pathological hallmark of a clinically heterogeneous set of neurodegenerative diseases…”
Get full text
Journal Article -
4
GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils
Published in The Journal of neuroscience (22-11-2017)“…Neurodegenerative proteinopathies characterized by intracellular aggregates of tau proteins, termed tauopathies, include Alzheimer's disease (AD),…”
Get full text
Journal Article -
5
Stereotaxic Targeting of Alpha-Synuclein Pathology in Mouse Brain Using Preformed Fibrils
Published in Methods in molecular biology (Clifton, N.J.) (2019)“…The accumulation of intraneuronal inclusions containing misfolded alpha-synuclein (aSyn) within the central nervous system (CNS) is a common feature found in…”
Get more information
Journal Article -
6
Accelerated Aβ Deposition in APPswe/PS1ΔE9 Mice with Hemizygous Deletions of TTR (Transthyretin)
Published in The Journal of neuroscience (27-06-2007)“…A cardinal pathological lesion of Alzheimer's disease (AD) is the deposition of amyloid β (Aβ) in the brain. We previously reported that exposing transgenic…”
Get full text
Journal Article -
7
Accelerated A{beta} Deposition in APPswe/PS1 Delta E9 Mice with Hemizygous Deletions of TTR (Transthyretin)
Published in The Journal of neuroscience (01-06-2007)“…A cardinal pathological lesion of Alzheimer's disease (AD) is the deposition of amyloid {szligbeta} (A{szligbeta}) in the brain. We previously reported that…”
Get full text
Journal Article -
8
Accelerated A{beta} Deposition in APPswe/PS1{Delta}E9 Mice with Hemizygous Deletions of TTR (Transthyretin)
Published in The Journal of neuroscience (27-06-2007)Get full text
Journal Article -
9
Accelerated Abeta deposition in APPswe/PS1deltaE9 mice with hemizygous deletions of TTR (transthyretin)
Published in The Journal of neuroscience (27-06-2007)“…A cardinal pathological lesion of Alzheimer's disease (AD) is the deposition of amyloid beta (Abeta) in the brain. We previously reported that exposing…”
Get full text
Journal Article